Original Research
Published on 13 Dec 2024
Modification of gemcitabine with oxaliplatin in China for unresectable gallbladder cancer: a cost-effectiveness analysis
in Health Economics
- 776 views
Original Research
Published on 13 Dec 2024
in Health Economics
Original Research
Published on 13 Dec 2024
in Health Economics
Original Research
Published on 11 Dec 2024
in Health Economics
Perspective
Published on 11 Dec 2024
in Health Economics
Original Research
Published on 10 Dec 2024
in Health Economics
Original Research
Published on 10 Dec 2024
in Health Economics
Original Research
Published on 06 Dec 2024
in Health Economics
Original Research
Published on 04 Dec 2024
in Health Economics
Original Research
Published on 04 Dec 2024
in Health Economics
Original Research
Published on 03 Dec 2024
in Health Economics
Original Research
Published on 02 Dec 2024
in Health Economics
Systematic Review
Published on 21 Nov 2024
in Health Economics
Original Research
Published on 20 Nov 2024
in Health Economics
Original Research
Published on 20 Nov 2024
in Health Economics
Original Research
Published on 20 Nov 2024
in Health Economics
Original Research
Published on 19 Nov 2024
in Health Economics